Tesaro, ENGOT Announce Successful Phase 3 Clinical Trial Results For Ovarian Cancer Drug Niraparib Clinical trial results show that Tesaro’s new drug niraparib could delay the recurrence of ovarian cancer. It also increased progression-free survival rates in women treated successfully with second-line chemotherapy. by Saranya Palanisamy